Vaccine Approval Update

The urgency surrounding vaccine approvals for children is palpable, with ongoing trials and data collection being prioritized. While frustrations may arise due to the pace of progress, it's emphasized that accuracy is paramount in this crucial process. Expectations are set for Moderna's data submission to the FDA by late October or early November, with both the FDA and CDC committed to swift reviews.